Back to products
Growth
CJC-1295 with DAC
Growth hormone releasing
$110
AUD · 2mg vial
99.1% purity
COA included
Lyophilised
In stock
A long-acting GHRH analogue studied for sustained growth hormone release and IGF-1 elevation.
Research use only. Not for human consumption, diagnosis, or therapeutic use. For in-vitro and laboratory research purposes only.
- Sustained GH release profile
- Supports IGF-1 elevation
- Studied for body composition effects
- Reduced injection frequency
CJC-1295 with DAC (Drug Affinity Complex) is a modified form of growth hormone releasing hormone (GHRH) with an extended half-life of up to 8 days. It is studied for its ability to sustainably elevate endogenous growth hormone and IGF-1.
Supplied with DAC for extended binding to serum albumin.
